ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,917Medicare Part D Prescriptions Filled, Including Refills

Rank: 231 out of 2399

$870K Total Retail Price of All Prescriptions

Rank: 252 out of 2399

542 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Pennsylvania
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 827 760 115 1 2
OMEPRAZOLE 747 682 116 2 5
AMLODIPINE BESYLATE 651 628 102 3 4
LISINOPRIL 457 408 74 4 3
ATORVASTATIN CALCIUM 415 385 75 5 7
SIMVASTATIN 351 320 50 6 1
METOPROLOL TARTRATE 323 303 56 7 8
METOPROLOL SUCCINATE 313 302 50 8 12
LOSARTAN POTASSIUM 313 313 51 8 16
METFORMIN HCL 309 267 39 10 9
CLOPIDOGREL 308 291 41 11 14
WARFARIN SODIUM 296 291* 40 12 10
FUROSEMIDE 282 254 61 13 6
GLIMEPIRIDE 252 221 40 14 43
HYDROCHLOROTHIAZIDE 247 242* 39 15 11
PRAVASTATIN SODIUM 217 192 39 16 18
ZETIA 215 210* 30 17 54
PANTOPRAZOLE SODIUM 211 192 36 18 20
POTASSIUM CHLORIDE 194 182 24 19 21
HYDROCODONE-ACETAMINOPHEN 185 165 38 S3 20 15
ALLOPURINOL 178 173* 28 21 32
LOVASTATIN 173 162 29 22 55
CRESTOR 171 166* 28 23 31
DIOVAN 170 165* 27 24 30
ATENOLOL 170 170 31 24 13
NEXIUM 158 137 19 26 35
CITALOPRAM HBR 155 150* 23 27 22
AMLODIPINE BESYLATE-BENAZEPRIL 147 132 22 28 69
TRAMADOL HCL-ACETAMINOPHEN 143 138* 55 29 202
CLONIDINE HCL 138 133* 19 30 77
ALPRAZOLAM 137 116 37 B 31 23
BENICAR 137 137 19 31 97
LOSARTAN-HYDROCHLOROTHIAZIDE 132 102 20 33 57
JANUVIA 126 109 22 34 48
METFORMIN HCL ER 116 111* 24 35 87
LORAZEPAM 114 109* 29 B 36 19
KLOR-CON M20 113 108* 19 37 46
TAMSULOSIN HCL 110 105* 18 38 27
ZOLPIDEM TARTRATE 98 78 17 39 29
AZITHROMYCIN 94 68 82 40 47
SYNTHROID 94 94 11 40 40
GABAPENTIN 90 75 14 42 17
MELOXICAM 90 85* 34 42 68
NIFEDIPINE ER 87 87 12 44 94
DONEPEZIL HCL 86 86 11 45 26
NAMENDA 86 86 12 45 33
ESCITALOPRAM OXALATE 85 74 15 47 39
GLYBURIDE 81 76* 13 R 48 96
LABETALOL HCL 80 80 12 49 155
ISOSORBIDE MONONITRATE ER 77 77 13 50 36
CARVEDILOL 75 64 13 51 28
VALSARTAN-HYDROCHLOROTHIAZIDE 71 71 13 52 66
EXFORGE 70 <11 <11 53 190
LYRICA 69 64* 13 54 108
CELEBREX 69 64* 16 54 72
PREDNISONE 67 67 12 56 38
METHYLPREDNISOLONE 66 55 50 57 116
PIOGLITAZONE HCL 66 <11 <11 R 57 102
PROAIR HFA 66 61* 18 57 70
SPIRIVA 65 60* 13 60 49
XARELTO 65 <11 <11 60 147
FLUTICASONE PROPIONATE 62 50 32 62 42
DIGOX 62 <11 <11 62 62
RAMIPRIL 61 <11 <11 64 95
AGGRENOX 60 <11 <11 65 166
ALENDRONATE SODIUM 60 <11 <11 65 34
SERTRALINE HCL 60 <11 <11 65 24
FELODIPINE ER 59 <11 <11 68 136
BENAZEPRIL HCL 59 47 12 68 119
BUSPIRONE HCL 59 <11 <11 68 134
DILTIAZEM 24HR ER 57 57 11 71 75
EVISTA 55 <11 <11 72 142
ADVAIR DISKUS 54 49* 11 73 37
FLUOXETINE HCL 53 <11 <11 74 83
TORSEMIDE 53 <11 <11 74 161
MECLIZINE HCL 50 45* 15 76 104
CLONAZEPAM 50 <11 <11 B 76 52
COLESTIPOL HCL 50 <11 <11 76 349
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.